metronidazole vaginal (metronidazole) NDC 70518-4572

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4572Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4572Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4572-0	70518457200	1 TUBE, WITH APPLICATOR in 1 CARTON (70518-4572-0) / 70 g in 1 TUBE, WITH APPLICATORMarketed from Feb 11, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): metronidazole vaginal
Generic name (nonproprietary): metronidazole
Active ingredients: Metronidazole — 7.5 mg/g
Dosage form: Gel
Route: Vaginal
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216750
Marketing start: Feb 11, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Nitroimidazoles (Chemical structure)
Identifiers: Product ID 70518-4572_4aa07119-00c9-2fef-e063-6394a90a4a9aSPL ID 4aa07119-00c9-2fef-e063-6394a90a4a9aSPL set ID b07f42dd-75d4-499a-984f-c06894ff3a45RxCUI 142046UNII 140QMO216E
Pharmacologic class: Nitroimidazole Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470518457200 followed by a unit qualifier and the quantity

Package 70518-4572-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 12, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Metronidazole vaginal gel is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis). NOTE For purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a pH of greater than 4.5, (b) emits a "fishy" amine odor when mixed with a 10% KOH solution, and (c) contains clue cells on microscopic examination. Gram's stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent Lactobacillus morphology, (b…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216750

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216750
Product	Strength	Form · route	Labeler	Product NDC
metronidazole vaginalmetronidazole	Metronidazole 7.5 mg/g	GelVaginal	Saptalis Pharmaceuticals LLC	71656-067